| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.02 | 0.7 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.069 | 0.7 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.027 | 0.7 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.055 | 0.7 |